The genetic polymorphisms of β3-adrenergic receptor (AR) Trp64Arg and β2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 4, 2007, Pages 493-498

  Mo, Wei ^a   Zhang, Guang Gan ^b   Yang, Tian Lun ^b   Dai, Xing Ping ^b   Li, Hui Hua ^a   Zeng, Hui ^a   Liu, Jie ^a   Tan, Yuan Ming ^a   Zhou, Hong Hao ^a   Liu, Zhao Qian ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

2 adrenergic receptor; 3 adrenergic receptor; Genetic polymorphism; Haplotype; Obesity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; ARGININE; GLUTAMIC ACID; GLYCINE; PRIMER DNA; TRYPTOPHAN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; CHINESE; CONTROL GROUP; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; GENETICS; HYPERTENSION; MIDDLE AGED; NUCLEOTIDE SEQUENCE;

AGED; ARGININE; BASE SEQUENCE; DNA PRIMERS; GLUTAMIC ACID; GLYCINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN;

EID: 34247350423     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.089     Document Type: Article

References (37)

1. El-Atat F, Aneja A, McFarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am 2003;32:823-54.
2. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res 2004;59:169-205.
3. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45:9-14.
4. Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992;20(Suppl 8):S40-8.
5. Julius S. The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension. Clin Exp Hypertens 1996;18:305-21.
6. Landsberg L. A teleological view of obesity, diabetes and hypertension. Clin Exp Pharmacol Physiol 2006;33:863-7.
7. Ambrosioni E, Bacchelli S, Esposti DD, Borghi C. Beta-blockade in hypertension and congestive heart failure. J Cardiovasc Pharmacol 2001;38(Suppl 3):S25-31.
8. Green SA, Turki J, Hall IP, Liggett SB. Implications of genetic variability of human beta 2-adrenergic receptor structure. Pulmon Pharmacol 1995;8:1-10.
9. Wood AJ. Variability in beta-adrenergic receptor response in the vasculature: role of receptor polymorphism. J Allergy Clin Immunol 2002;110(Suppl 6):S318-21.
10. Wechsler ME. Managing asthma in the 21st century: role of pharmacogenetics. Pediatr Ann 2006;35:660-9.
11. Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 2003;74:372-9.
12. 1- Adrenergic receptor polymorphism influences the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther 2006;80:23-32.
13. Lipworth BJ. Clinical pharmacology of [beta]3-adrenoceptors. Br J Clin Pharmacol 1996;42:291-300.
14. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD. Pharmacological characterization of a recently described human b3-adrenergic receptor mutant. Endocrinology 1996;137:2638-41.
15. Hoffstedt J, Poirier O, Thorne A, Lonnqvist F, Herrmann SM, Cambien F, et al. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999;48:203-5.
16. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, et al. Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertension 2001;19:399-406.
17. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-9.
18. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human β2-adrenergic receptor impact distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9.
19. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J, et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2002;26:928-37.
20. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphism of the 59 leader cistron of the human beta-2 adrenergic receptor regulates receptor expression. J Clin Invest 1998;102:1927-32.
21. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shiqemoto S, et al. The Gln27Glu β2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999;258:138-40.
22. Ehrenborg E, Skogsberg J, Ruotolo G, Large V, Eriksson P, Arner P, Hamsten A. The Q/E27 polymorphism in the β2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceriderich lipoproteins. J Intern Med 2000;247:651-6.
23. He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes 2001;25:748-52.
24. World Health Organization. The Asian-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia: Health Communication 2000:1-56.
25. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH. Impact of obesity and body fat distribution on cardiovascular risk factor in Hong Kong Chinese. Obesity Res 2004;12:1805-13.
26. The 6th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
27. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, et al. Genetic variation in the β3-adrenoceptor receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-4.
28. Chang TJ, Tsai MH, Jiang YD, Lee B, Lee KC, Lin JY, et al. The Arg16Gly polymorphism of human β2 adrenoreceptor is associated with type 2 diabetes in Taiwanese people. Clin Endocrinol 2002;57:685-90.
29. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, et al. Frequency of functionally important β-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999;9:511-6.
30. MacLean CJ, Morton NE. Estimation of myriad haplotype frequencies. Genet Epidemiol 1985;2:263-72.
31. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P. The different effects of a Gln27Glu β2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999;245:253-9.
32. Pietri-Rouxel F, St John Manning B, Gros J, Strosberg AD. The biochemical effect of the naturally occurring Trp64→Arg mutation on human beta3-adrenoceptor activity. Eur J Biochem 1997;247:1174-9.
33. Ukkola O, Tremblay A, Bouchard C. β2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord 2001;25:1604-8.
34. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Impact of polymorphisms of the human β2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000;24:382-7.
35. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, et al. Tissue distribution of beta3-adrenergic receptor mRNA in man. J Clin Invest 1993;91:344-9.
36. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:667-73.
37. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region beta2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000;97:10483-88.